The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.70
Bid: 21.70
Ask: 21.85
Change: -0.10 (-0.46%)
Spread: 0.15 (0.691%)
Open: 21.00
High: 22.10
Low: 21.00
Prev. Close: 21.80
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful Completion of A$8million Equity Placing

15 Dec 2023 07:00

RNS Number : 9672W
Atlantic Lithium Limited
15 December 2023
 

15 December 2023

Successful Completion of A$8 million Equity Placing

Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlantic Lithium" or the "Company"), the African-focused lithium exploration and development company targeting to deliver Ghana's first lithium mine, is pleased to announce it has successfully completed its institutional placement ("Equity Placing"), as announced on 14 December 2023 ("Launch Announcement"), raising A$8.0 million (equivalent to approximately £4.2 million) at a price of A$0.44 (23.35 pence) per New Share ("Issue Price"). A total of 18,181,819 new fully paid ordinary shares of no-par value each in the Company will be issued ("New Shares").

Proceeds will enable the completion of the activities agreed under the grant of the Mining Lease for the Project, key items of early works and permitting-related Project expenditure, for further extensional drilling to support the delivery of an upgraded Mineral Resource Estimate for the Project in Q3 2024, and for working capital purposes.

Canaccord Genuity (Australia) Limited ("Canaccord") is acting as Lead Manager ("Lead Manager") to the Equity Placement. Wilsons Advisory & Stockbroking is acting as Co-Manager ("Co-Manager").

 

Commenting, Neil Herbert, Executive Chairman of Atlantic Lithium, said:

"Through the support of our existing institutional shareholder base and in welcoming a number of new institutions onto our register, we are pleased to have successfully raised A$8 million. As we await the completion and the receipt of the funds from the Minerals Income Investment Fund's investment, as well as the completion of the off-take process that is currently underway, the proceeds put the Company in a strong position to continue advancing the Ewoyaa Lithium Project at pace.

"The Placing enables us to fund the numerous activities that are underway or imminent that seek to add further value to the Project, aligning with the growth ambitions of the Company.

"With a number of key milestones ahead of us, we look forward to providing further updates on our progress in due course."

 

Allotment and Admission

Application will be made to the London Stock Exchange and the Australian Securities Exchange for admission of the 18,181,819 New Shares to trading on AIM and ASX, expected to take place at 8:00 a.m. on 22 December 2023 on AIM and 10:00 a.m. on 22 December 2023 Sydney time on ASX.

Total Voting Rights

Following Admission, there will be 630,423,479 Ordinary Shares in issue carrying voting rights admitted to trading (on AIM and ASX). This figure 630,423,479 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the market abuse regulation (EU) no. 596/2014 as it forms part of UK domestic law pursuant to the European Union (withdrawal) Act 2018, as amended. Upon the publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

 

For any further information, please contact:

Atlantic Lithium Limited

Neil Herbert (Executive Chairman)

Amanda Harsas (Finance Director and Company Secretary)

www.atlanticlithium.com.au

IR@atlanticlithium.com.au

Tel: +61 2 8072 0640

SP Angel Corporate Finance LLP

Nominated Adviser

Jeff Keating

Charlie Bouverat

Tel: +44 (0)20 3470 0470

Yellow Jersey PR Limited

Charles Goodwin

Bessie Elliot atlantic@yellowjerseypr.com

Tel: +44 (0)20 3004 9512

 

Canaccord Genuity Limited

Financial Adviser:

Raj Khatri (UK) /

Duncan St John, Christian Calabrese (Australia)

 

Corporate Broking:

James Asensio, Harry Rees

Tel: +44 (0) 20 7523 4500

 

Notes to Editors:

 

About Atlantic Lithium

www.atlanticlithium.com.au

Atlantic Lithium is an AIM and ASX-listed lithium company advancing a portfolio of lithium projects in Ghana and Côte d'Ivoire through to production.

The Company's flagship project, the Ewoyaa Project in Ghana, is a significant lithium spodumene pegmatite discovery on track to become Ghana's first lithium-producing mine.

The Definitive Feasibility Study for the Project indicates the production of 3.6Mt of spodumene concentrate over a 12-year mine life, making it one of the top 10 largest spodumene concentrate mines in the world.

The Project, which was awarded a Mining Lease in October 2023, is being developed under a funding agreement with Piedmont Lithium Inc.

Atlantic Lithium holds 509km2 and 774km2 of tenure across Ghana and Côte d'Ivoire respectively, comprising significantly under-explored, highly prospective licences.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTABFTMTIBMAJ
Date   Source Headline
2nd Oct 201312:55 pmRNSExercise of Share Options
1st Oct 20133:29 pmRNSNotification of Major Interest in Shares
30th Sep 20135:17 pmRNSNotification of Major Interest in Shares
30th Sep 20139:46 amRNSNotification of Major Interest in Shares
30th Sep 20137:00 amRNSNotification of Major Interest in Shares
23rd Sep 20131:28 pmRNSNotification of Major Interest in Shares
23rd Sep 20137:09 amRNSRetirement of Director & Director Shareholding
23rd Sep 20137:05 amRNSExercise of Options & Director/PDMR Shareholding
20th Sep 20137:00 amRNSExercise of Share Options
18th Sep 20132:53 pmRNSDirector Shareholding
28th Aug 20137:00 amRNSExercise of Share Options
9th Aug 20139:01 amRNSExercise of Share Options
2nd Aug 20133:18 pmRNSExercise of Share Options
31st Jul 20131:30 pmRNSDividend Payment Date
23rd Jul 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSTrading Update
20th May 201310:19 amRNSExercise of Options
15th May 20131:08 pmRNSNotification of Major Interest in Shares
7th May 201310:25 amRNSExercise of Options
2nd May 20139:26 amRNSExercise of Options
29th Apr 20138:31 amRNSExercise of Options
26th Apr 20139:49 amRNSExercise of Options
27th Mar 20135:06 pmRNSExercise of Options
25th Mar 20133:30 pmRNSNotification of Major Interest in Shares
25th Mar 20137:05 amRNSNotification of Major Interest In Shares
22nd Mar 20132:16 pmRNSExercise of Options
6th Mar 20134:30 pmRNSHolding(s) in Company
6th Mar 20132:08 pmRNSHolding(s) in Company
26th Feb 20131:12 pmRNSExercise of Options
11th Feb 201310:59 amRNSHolding(s) in Company
11th Feb 201310:53 amRNSHolding(s) in Company
11th Feb 201310:51 amRNSHolding(s) in Company
5th Feb 20137:00 amRNSHalf Yearly Report
16th Jan 20137:00 amRNSNotice of Results
8th Jan 20137:00 amRNSFirst Half Trading Update
23rd Nov 20123:18 pmRNSResult of AGM
31st Oct 20127:00 amRNSBoard Appointment
29th Oct 20127:00 amRNSNotice of AGM
18th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 20129:56 amRNSNotification of Major Interest in Shares
1st Oct 20121:14 pmRNSTrading Update
19th Sep 20124:01 pmRNSExercise of Options
15th Aug 20124:35 pmRNSGrant of Share Options to Directors
15th Aug 20127:05 amRNSAnnual Accounts 2012
13th Aug 20123:27 pmRNSNotification of Major Interest in Shares
13th Aug 201210:15 amRNSNotification of Major Interest in Shares
31st Jul 20127:05 amRNSRecord Final Results FYE 31 May 2012
31st Jul 20127:00 amRNSAcquisition of RealTime Health
16th Jul 20127:00 amRNSNotice of Results
26th Jun 20127:00 amRNSFull Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.